Areas of Expertise
Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
The information contained in this page is intended for U.S. healthcare professionals only.
Baxter provides a comprehensive range of anesthesia products including inhalation anesthetics and a broad range of generic injectables and regional anesthesia.
In surgery, the ability of the surgeon to control bleeding and seal tissue quickly can help reduce complications and lead to improved surgical procedures. Baxter provides therapeutic solutions for biosurgery and tissue regeneration in many surgical specialties with biological products, preparation/delivery devices, and physician resources.
Baxter's critical care therapies includes albumin which is primarly used as plasma-volume replacement therapy for the treatment of hypovolemia, Hypoalbuminemia, Burns, Adult Respiratory Distress Syndrome, Nephrosis, Cardiopulmonary Bypass Surgery, Hemolytic Disease of the Newborn.
Our long-standing commitment to provide high-quality therapies for people with hemophilia has led to innovations including the first plasma/albumin-free method recombinant Factor VIII therapy, and monoclonal antibody purification and heat treatment processes.
Baxter provides purified plasma treatments containing antibodies called immunoglobulins that help Primary Immune Deficiency patients fight off infection.
Baxter's pulmonology therapy focuses on patients with alpha-1 antitrypsin deficiency (AATD).
Renal therapies: treatments for patients with kidney failure.
Baxter has long been committed to developing dialysis systems and solutions to enhance therapy outcomes for a wide range of patients with a wide range of needs.
Continuous renal replacement therapy
Continuous Renal Replacement Therapy (CRRT) is a safe, effective option for patients with AKI (Acute Kidney Injury).
In-center hemodialysis is an option for kidney disease patients who choose to get treatment at a dialysis unit in a clinical setting or a hospital, rather than performing dialysis at home
All vaccines-related content is available under Press Room > Fact sheets. Our targeted audience is the press and the investment community. The link is provided in this section for ease of location only.